[[Publications List]](publications.md)  [[CABS Ranked]](ref.md)

# Clinical Trials

_Clinical trials coordinated statistically as Senior Statistician at the Hellenic Cooperative Oncology Group (HeCOG)_

---

## Lung Cancer

[5] ClinicalTrials.gov Identifier: **[NCT03568097](https://clinicaltrials.gov/study/NCT03568097)** - PAVE: Intercalated Avelumab plus platinum-based chemotherapy in patients with Extensive-Stage Small-Cell Lung Cancer
   * Mountzios, G., Papadopoulou, K., Korfiatis, N., Goussia, A., Samantas, E., et al. (2025). Intercalated Avelumab plus platinum-based chemotherapy in patients with Extensive-Stage Small-Cell Lung cancer (PAVE): Final Outcome, Immunophenotypic and biomarker analysis. *European Journal of Cancer*, 228, 115660.

[4] ClinicalTrials.gov Identifier: **[NCT05372081](https://clinicaltrials.gov/study/NCT05372081)** - SNF-CLIMEDIN: Digital support and intervention in patients with advanced NSCLC
   * Kosmidis, P.A., Kosmidis, T., Papadopoulou, K., Korfiatis, N., Vozikis, A., et al. (2025). SNF-CLIMEDIN: A HECOG prospective randomized trial of digital support and intervention in patients with advanced NSCLCâ€”Final results. *Journal of Clinical Oncology*, 43(16_suppl), 1515-1515.

---

## Colorectal Cancer

[3] ClinicalTrials.gov Identifier: **[NCT03311750](https://clinicaltrials.gov/study/NCT03311750)** - A-REPEAT: Anti-EGFR re-challenge with chemotherapy in RAS wild-type advanced colorectal cancer
   * Sgouros, J., Eliades, A., Papadopoulou, K., Korfiatis, N., Papamichael, D., et al. (2025). Anti-EGFR re-challenge with chemotherapy in RAS wild-type advanced colorectal cancer (A-REPEAT study): efficacy and correlations with tissue and plasma genotyping. *ESMO Gastrointestinal Oncology*, 7, 100120.

---

## Prostate Cancer

[2] ClinicalTrials.gov Identifier: **[NCT02512458](https://clinicaltrials.gov/study/NCT02512458)** - CabaBone: Cabazitaxel in patients with castration-resistant prostate cancer and osseous metastases
   * Liontos, M., Goussia, A., Korfiatis, N., Papadopoulou, K., Kanellis, G., Visvikis, A., et al. (2025). The role of Cabazitaxel in Patients With Castration-Resistant and Osseous Metastases Prostate Cancer: A Hellenic Cooperative Oncology Group Phase II Study. *Clinical Genitourinary Cancer*, 23(1), 102253.

---

## Breast Cancer

[1] ClinicalTrials.gov Identifier: **[NCT04829890](https://clinicaltrials.gov/study/NCT04829890)** - Dose-dense sequential adjuvant chemotherapy in patients with resected high-risk breast cancer
   * Goussia, A., Dimitrakopoulos, F.I.D., Korfiatis, N., Koletsa, T., Batistatou, A., et al. (2025). Clinical outcomes and important prognostic biomarkers following dose-dense sequential adjuvant chemotherapy (dds-CT) in early breast cancer (eBC): Pooled-analysis of individual patient data. *ESMO Open*, 10.
